
Expa

Parkwalk Advisors

Over £400m raised; invested into over 150 companies
Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns
Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses
Oxford Endovascular is developing next-generation medical devices for neurovascular disease The Company’s sophisticated metallic mesh tube devices and systems can be used to treat patients suffering from brain aneurysms The tubes are made from a special metal alloy which has a shape memory and unfolds in the blood vessel when in place The product and Cytoseek’s novel cell membrane augmentation technology enables the addition of new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability A spin-out from the University of Bristol, CytoSeek’s technology is based on the research of Dr Adam Perriman, who pioneered a new methodology for the rational design of synthetic artificial membrane- Focal Point Positioning has developed software which offers highly accurate positioning information for smartphones both indoors and outdoors in urban areas Locating people or objects using existing technology is problematic in such spaces but the team’s work on systems as diverse as submarines and Martian rovers has given them a technological edge in the field
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Parkwalk Advisors.
Similar listings buyers compare against this one.

Expa

Applied Materials

Analog Devices

Kleiner Perkins Caufield & Byers

Coinbase Ventures

Alsop Louie Partners
Everything here links back to the same verified catalogue. Pick your next stop.